4.6 Article

Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies

Alessia Catalano et al.

Summary: Multidrug resistance, including resistance to anticancer agents and antimicrobial drugs, is a significant concern in public health. The widespread use of antibiotics has led to the emergence of pathogenic bacteria resistant to multiple drugs, and the ongoing COVID-19 pandemic may worsen antimicrobial resistance. Nanodrug delivery systems have shown promise in overcoming resistance.

MOLECULES (2022)

Article Pharmacology & Pharmacy

Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship

Malcolm B. Gillies et al.

Summary: The study examined the impact of COVID-19 restrictions on antibiotic dispensing trends in Australia, finding a significant reduction in antibiotics prescribed for respiratory infections coinciding with the increase in telehealth consultations. The findings suggest the potential to reduce inappropriate prescribing for respiratory viral infections by GPs and specialists in a post-pandemic setting.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Letter Public, Environmental & Occupational Health

Impact of the strategies implemented by an antimicrobial stewardship program on the antibiotic consumption in the coronavirus disease 2019 (COVID-19) pandemic

Anna Murgadella-Sancho et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Review Virology

COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies

Domenico Iacopetta et al.

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus poses a severe threat to public health. The search for vaccines has led to the approval of about twenty COVID-19 vaccines, but new genetic mutations and variants continue to emerge, necessitating pharmacological treatments.Various treatments, including antivirals, antibiotics, immunomodulators, vitamins, and drug repositioning, are being used to combat the spread of the virus.

VIRUSES-BASEL (2022)

Article Infectious Diseases

Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic

Santiago Grau et al.

Summary: The study found an increase in antimicrobial consumption during the first wave of COVID-19 pandemic, especially in the ICU. Different antibiotics showed a clear temporal pattern in their usage. Availability of updated protocols and antimicrobial stewardship programs are essential to optimize these outcomes.

ANTIBIOTICS-BASEL (2021)

Article Infectious Diseases

Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England

Aleksandra J. Borek et al.

Summary: The study found that the COVID-19 pandemic had impacted antibiotic prescribing and antimicrobial stewardship in general practice in England, leading to lower thresholds for prescribing antibiotics and changes in consultation methods. Participants reported decreased engagement with AMS due to COVID-19-related urgent priorities. Re-engagement with AMS is needed to identify opportunities for future management of infections and AMS.

ANTIBIOTICS-BASEL (2021)

Review Public, Environmental & Occupational Health

Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance

Jesus Rodriguez-Bano et al.

Summary: During the COVID-19 pandemic, inappropriate and excessive antibiotic prescribing in SARS-CoV-2 patients has highlighted weaknesses in antimicrobial stewardship programs, with a deprioritization of surveillance and containment of antimicrobial resistance. Long-term global surveillance, implementation research, and internationally coordinated AMR research are necessary to prepare for future challenges from emerging resistance in the context of current and future pandemics.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2021)

Article Infectious Diseases

Surveillance of Antibacterial Usage during the COVID-19 Pandemic in England, 2020

Amelia Andrews et al.

Summary: During the COVID-19 pandemic, there was a decrease in antibacterial prescribing in the community, while overall antibacterial use in hospitals decreased, with increases observed in specific antibacterials. This emphasizes the importance of antimicrobial stewardship during pandemics to ensure appropriate prescribing and prevent negative consequences on patient outcomes and antimicrobial resistance.

ANTIBIOTICS-BASEL (2021)

Article Infectious Diseases

Antibiotic Use during the COVID-19 Pandemic in a Tertiary Hospital with an Ongoing Antibiotic Stewardship Program

Oryan Henig et al.

Summary: Targeted antibiotic stewardship programs have been shown to significantly reduce antibiotic consumption during the COVID-19 pandemic, particularly in cases where clinical manifestations may be confused with bacterial infections. This highlights the effectiveness of such programs in managing antibiotic use in viral diseases like COVID-19.

ANTIBIOTICS-BASEL (2021)

Letter Medicine, General & Internal

Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020

Wei Yee Wan et al.

JAMA NETWORK OPEN (2021)

Editorial Material Public, Environmental & Occupational Health

Interrupting transmission of COVID-19: lessons from containment efforts in Singapore

Vernon J. Lee et al.

JOURNAL OF TRAVEL MEDICINE (2020)

Review Medical Laboratory Technology

Biomarkers associated with COVID-19 disease progression

Giovanni Ponti et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)

Editorial Material Public, Environmental & Occupational Health

Tackling antimicrobial resistance in the COVID-19 pandemic

Haileyesus Getahun et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)

Editorial Material Microbiology

Antimicrobial use, drug-resistant infections and COVID-19

Timothy M. Rawson et al.

NATURE REVIEWS MICROBIOLOGY (2020)

Article Infectious Diseases

PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates

Cornelius J. Clancy et al.

JAC-ANTIMICROBIAL RESISTANCE (2020)

Article Infectious Diseases

Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials

Philipp Schuetz et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)

Review Infectious Diseases

Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management

Farnaz Foolad et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Review Medicine, General & Internal

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

Philipp Schuetz et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Immunology

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia

Wesley H. Self et al.

CLINICAL INFECTIOUS DISEASES (2017)

Review Infectious Diseases

Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies

Antonio Teixeira Rodrigues et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)